To investigate the in vivo regulatory role of MRPL21 in tumor progression, we established an HNSCC xenograft model by subcutaneously injecting cells harboring knockdown of MRPL21 and PARP1-overexpressing cells, as well as control cells, into nude mice. This evidence concerns the gene PARP1 and head and neck squamous cell carcinoma.